Summary

Persistence Market Research has recently released an extensive report on the global Rheumatoid Arthritis (RA) Market, offering a thorough analysis of market dynamics, including key drivers, trends, opportunities, and challenges. This comprehensive report provides valuable insights into the market structure and its growth potential through the forecast period.

Key Insights:

• Rheumatoid Arthritis Market Size (2024E): USD 760.4 million
• Projected Market Value (2033F): USD 1,200 million
• Global Market Growth Rate (CAGR 2024 to 2033): 5.2%

Rheumatoid Arthritis Market - Report Scope:

Rheumatoid arthritis is a chronic autoimmune disorder characterized by inflammation and deformity of the joints. The market for RA treatments includes pharmaceuticals, biologics, and advanced therapies aimed at managing symptoms and improving the quality of life for patients. The growth of this market is driven by increasing prevalence of RA, advancements in drug development, and a rising awareness of the disease.

Market Growth Drivers:

Several key factors are driving the growth of the global Rheumatoid Arthritis Market: • Rising Incidence: The growing incidence of RA, driven by an aging population and lifestyle factors. • Advancements in Therapies: Improvements in biologic therapies and targeted treatments are enhancing patient outcomes and expanding options. • Personalized Medicine: Increased focus on personalized medicine and precision treatments. • R&D Activities: Ongoing research and development, along with a rise in clinical trials, is expected to introduce innovative therapies.

Market Restraints:

Despite its growth potential, the Rheumatoid Arthritis Market faces several challenges: • High Treatment Costs: The cost of advanced therapies and biologics can be prohibitively high, limiting access for some patients. • Side Effects and Efficacy Issues: Some treatments have side effects or variable efficacy, impacting patient adherence and market dynamics. • Regulatory Hurdles: Navigating complex regulatory requirements can be challenging and time-consuming, potentially delaying market entry for new therapies.

Market Opportunities:

The market presents substantial growth opportunities: • Emerging Markets: Growing healthcare infrastructure and rising awareness in emerging markets offer expansion opportunities. • Innovative Therapies: Continued development of targeted and personalized therapies promises improved treatment outcomes. • Strategic Collaborations: Partnerships between pharmaceutical companies and research institutions can accelerate drug development and market penetration. • Digital Health: Integration of digital health solutions and telemedicine can enhance disease management and patient engagement.

Key Questions Answered in the Report:

• What are the primary factors driving the global Rheumatoid Arthritis Market?
• Which regions and demographics are experiencing the highest prevalence of RA?
• How are advancements in RA treatments impacting the competitive landscape?
• Who are the leading players in the Rheumatoid Arthritis Market, and what strategies are they employing to strengthen their market positions?
• What are the emerging trends and future prospects in the global Rheumatoid Arthritis Market?

Competitive Intelligence and Business Strategy:

Leading players in the Rheumatoid Arthritis Market, including companies like Pfizer, AbbVie, and Johnson & Johnson, are focusing on: • Innovation: Investing in the development of advanced therapies. • R&D: Expanding their product portfolios and enhancing patient access. • Strategic Partnerships: Collaborating with healthcare providers and research institutions. • Compliance and Technology: Adhering to industry standards and leveraging new technologies to maintain a competitive edge.

Key Companies Profiled:

• Abbott Diagnostics
• Antibodies Incorporated
• Beckman Coulter, Inc.
• Euro Diagnostica AB
• Thermo Fisher Scientific Inc.
• Qiagen N.V.
• F. Hoffmann-La Roche Ltd.
• Siemens Healthcare GmbH
• Janel Group (Antibodies Inc.)

Key Segments Covered in Rheumatoid Arthritis Industry Research:

Test Type:
• Serology Tests
• Monitoring Rheumatoid Arthritis Treatment Efficiency Tests

End User:
• Hospitals
• Diagnostic Laboratories
• Private Laboratories
• Public Laboratories
• Ambulatory Surgical Centers

Region:
• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa (MEA)

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Innovation / Development Trends
4. Key Success Factors
4.1. Adoption Analysis
4.2. Key Regulations
4.3. Cost Analysis, By Test Type
4.4. Reimbursement Scenario
4.5. Supply Chain Analysis
4.6. PESTLE Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP outlook
5.1.2. Global Healthcare Outlook
5.1.3. Global Autoimmune Disease Diagnostics Market Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Growing Healthcare Expenditure
5.2.2. Increasing Adoption of Rheumatoid Arthritis Diagnostic Tests
5.2.3. Prevalence of Arthritis Diseases
5.2.4. New Product Launches
5.2.5. Adoption of Off-Label Arthritis Diagnostic Procedures
5.2.6. Increasing Research Activities to Expand Diagnostic Methods
5.2.7. Study of Limited Specificity and Sensitivity of Rheumatoid Arthritis Test Kits
5.2.8. Growing Awareness about Chronic Diseases
5.2.9. Government Funding and Initiatives
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.1.1. By Test Type
6.1.2. By End User
6.1.3. By Country
6.2. 2024 Market Scenario
7. Global Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033
7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
7.2. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Test Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Test Type, 2019-2023
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Test Type, 2024-2033
8.3.1. Serology Test
8.3.1.1. Erythrocyte Sedimentation Rate (ESR)
8.3.1.2. Rheumatoid Factor (RF)
8.3.1.3. Anti–cyclic Citrullinated Peptide (anti–CCP)
8.3.1.4. Antinuclear Antibody (ANA)
8.3.1.5. Uric Acid
8.3.1.6. Other Test
8.3.2. Monitoring RA Treatment Efficiency Tests
8.3.2.1. Salicylate Level Count
8.3.2.2. Muscle Enzyme Test
8.3.2.3. Creatinine Test
8.4. Market Attractiveness Analysis By Test Type
9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis by End User, 2019-2023
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by End User, 2024-2033
9.3.1. Hospitals
9.3.2. Diagnostic Laboratories
9.3.2.1. Private Laboratories
9.3.2.2. Public Laboratories
9.3.3. Ambulatory Surgical Centers
9.4. Market Attractiveness Analysis by End User
10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis, by Region, 2019-2023
10.3. Current and Future Market Size (US$ Mn) Analysis Forecast by Region, 2024-2033
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. East Asia
10.3.5. South Asia
10.3.6. Oceania
10.3.7. Middle East & Africa
10.4. Market Attractiveness Analysis by Region
11. North America Market Analysis 2019-2023 and Forecast 2024-2033
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis Trend Analysis by Market Taxonomy, 2019-2023
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
11.3.1. By Country
11.3.1.1. U.S.
11.3.1.2. Canada
11.3.2. By Test Type
11.3.3. By End User
11.4. Market Attractiveness Analysis
11.4.1. By Country
11.4.2. By Test Type
11.4.3. By End User
11.5. Market Trends
11.6. Key Market Participants - Intensity Mapping
11.7. Drivers and Restraints - Impact Analysis
11.8. Country Level Analysis & Forecast
11.8.1. U.S. Market
11.8.1.1. Introduction
11.8.1.2. Market Analysis and Forecast by Market Taxonomy
11.8.1.2.1. By Test Type
11.8.1.2.2. By End User
11.8.2. Canada Market
11.8.2.1. Introduction
11.8.2.2. Market Analysis and Forecast by Market Taxonomy
11.8.2.2.1. By Test Type
11.8.2.2.2. By End User
12. Latin America Market Analysis 2019-2023 and Forecast 2024-2033
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2019-2023
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
12.3.1. By Country
12.3.1.1. Mexico
12.3.1.2. Brazil
12.3.1.3. Argentina
12.3.1.4. Rest of Latin America
12.3.2. By Test Type
12.3.3. By End User
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Test Type
12.4.3. By End User
12.5. Market Trends
12.6. Key Market Participants - Intensity Mapping
12.7. Drivers and Restraints - Impact Analysis
12.8. Country Level Analysis & Forecast
12.8.1. Mexico Market Analysis
12.8.1.1. Introduction
12.8.1.2. Market Analysis and Forecast by Market Taxonomy
12.8.1.2.1. By Test Type
12.8.1.2.2. By End User
12.8.2. Brazil Market Analysis
12.8.2.1. Introduction
12.8.2.2. Market Analysis and Forecast by Market Taxonomy
12.8.2.2.1. By Test Type
12.8.2.2.2. By End User
12.8.3. Argentina Market Analysis
12.8.3.1. Introduction
12.8.3.2. Market Analysis and Forecast by Market Taxonomy
12.8.3.2.1. By Test Type
12.8.3.2.2. By End User
13. Europe Market Analysis 2019-2023 and Forecast 2024-2033
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis Trend Analysis by Market Taxonomy, 2019-2023
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
13.3.1. By Country
13.3.1.1. Germany
13.3.1.2. Italy
13.3.1.3. France
13.3.1.4. U.K.
13.3.1.5. Spain
13.3.1.6. BENELUX
13.3.1.7. Russia
13.3.1.8. Rest of Europe
13.3.2. By Test Type
13.3.3. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Test Type
13.4.3. By End User
13.5. Market Trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
13.8. Country Level Analysis & Forecast
13.8.1. Germany Market Analysis
13.8.1.1. Introduction
13.8.1.2. Market Analysis and Forecast by Market Taxonomy
13.8.1.2.1. By Test Type
13.8.1.2.2. By End User
13.8.2. Italy Market Analysis
13.8.2.1. Introduction
13.8.2.2. Market Analysis and Forecast by Market Taxonomy
13.8.2.2.1. By Test Type
13.8.2.2.2. By End User
13.8.3. France Market Analysis
13.8.3.1. Introduction
13.8.3.2. Market Analysis and Forecast by Market Taxonomy
13.8.3.2.1. By Test Type
13.8.3.2.2. By End User
13.8.4. U.K. Market Analysis
13.8.4.1. Introduction
13.8.4.2. Market Analysis and Forecast by Market Taxonomy
13.8.4.2.1. By Test Type
13.8.4.2.2. By End User
13.8.5. Spain Market Analysis
13.8.5.1. Introduction
13.8.5.2. Market Analysis and Forecast by Market Taxonomy
13.8.5.2.1. By Test Type
13.8.5.2.2. By End User
13.8.6. BENELUX Market Analysis
13.8.6.1. Introduction
13.8.6.2. Market Analysis and Forecast by Market Taxonomy
13.8.6.2.1. By Test Type
13.8.6.2.2. By End User
13.8.7. Russia Market Analysis
13.8.7.1. Introduction
13.8.7.2. Market Analysis and Forecast by Market Taxonomy
13.8.7.2.1. By Test Type
13.8.7.2.2. By End User
14. East Asia Market Analysis 2019-2023 and Forecast 2024-2033
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2019-2023
14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
14.3.1. By Country
14.3.1.1. China
14.3.1.2. Japan
14.3.1.3. South Korea
14.3.2. By Test Type
14.3.3. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Test Type
14.4.3. By End User
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country Level Analysis & Forecast
14.8.1. China Market Analysis
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast by Market Taxonomy
14.8.1.2.1. By Test Type
14.8.1.2.2. By End User
14.8.2. Japan Market Analysis
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast by Market Taxonomy
14.8.2.2.1. By Test Type
14.8.2.2.2. By End User
14.8.3. South Korea Market Analysis
14.8.3.1. Introduction
14.8.3.2. Market Analysis and Forecast by Market Taxonomy
14.8.3.2.1. By Test Type
14.8.3.2.2. By End User
15. South Asia Market Analysis 2019-2023 and Forecast 2024-2033
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2019-2023
15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Indonesia
15.3.1.3. Malaysia
15.3.1.4. Thailand
15.3.1.5. Rest of South Asia
15.3.2. By Test Type
15.3.3. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Test Type
15.4.3. By End User
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country Level Analysis & Forecast
15.8.1. India Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Test Type
15.8.1.2.2. By End User
15.8.2. Indonesia Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast by Market Taxonomy
15.8.2.2.1. By Test Type
15.8.2.2.2. By End User
15.8.3. Malaysia Market Analysis
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast by Market Taxonomy
15.8.3.2.1. By Test Type
15.8.3.2.2. By End User
15.8.4. Thailand Market Analysis
15.8.4.1. Introduction
15.8.4.2. Market Analysis and Forecast by Market Taxonomy
15.8.4.2.1. By Test Type
15.8.4.2.2. By End User
16. Oceania Market 2019-2023 and Forecast 2024-2033
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2019-2023
16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
16.3.1. By Country
16.3.1.1. Australia
16.3.1.2. New Zealand
16.3.2. By Test Type
16.3.3. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Test Type
16.4.3. By End User
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country Level Analysis & Forecast
16.8.1. Australia Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Test Type
16.8.1.2.2. By End User
16.8.2. New Zealand Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Test Type
16.8.2.2.2. By End User
17. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Analysis Trend Analysis by Market Taxonomy, 2019-2023
17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
17.3.1. By Country
17.3.1.1. GCC Countries
17.3.1.2. Türkiye
17.3.1.3. North Africa
17.3.1.4. South Africa
17.3.1.5. Rest of Middle East and Africa
17.3.2. By Test Type
17.3.3. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Test Type
17.4.3. By End User
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country Level Analysis & Forecast
17.8.1. GCC Countries Market Analysis
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Test Type
17.8.1.2.2. By End User
17.8.2. Türkiye Market Analysis
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Test Type
17.8.2.2.2. By End User
17.8.3. South Africa Market Analysis
17.8.3.1. Introduction
17.8.3.2. Market Analysis and Forecast by Market Taxonomy
17.8.3.2.1. By Test Type
17.8.3.2.2. By End User
17.8.4. North Africa Market Analysis
17.8.4.1. Introduction
17.8.4.2. Market Analysis and Forecast by Market Taxonomy
17.8.4.2.1. By Test Type
17.8.4.2.2. By End User
18. Market Structure Analysis
18.1. Market Analysis by Tier of Companies
18.2. Market Share Analysis of Top Players
18.3. Market Presence Analysis
19. Competition Analysis
19.1. Competition Dashboard
19.2. Branding and Promotional Strategies
19.3. Key Development Analysis
19.4. Competition Deep Dive
19.4.1. Abbott Diagnostics
19.4.1.1. Overview
19.4.1.2. Service Portfolio
19.4.1.3. Sales Footprint
19.4.1.4. Key Financials
19.4.1.5. SWOT Analysis
19.4.1.6. Strategy Overview
19.4.1.6.1. Marketing Strategy
19.4.1.6.2. Diagnostic Test Strategy
19.4.1.6.3. Channel Strategy
19.4.2. Antibodies Incorporated
19.4.2.1. Overview
19.4.2.2. Service Portfolio
19.4.2.3. Sales Footprint
19.4.2.4. Key Financials
19.4.2.5. SWOT Analysis
19.4.2.6. Strategy Overview
19.4.2.6.1. Marketing Strategy
19.4.2.6.2. Diagnostic Test Strategy
19.4.2.6.3. Channel Strategy
19.4.3. Beckman Coulter, Inc.
19.4.3.1. Overview
19.4.3.2. Service Portfolio
19.4.3.3. Sales Footprint
19.4.3.4. Key Financials
19.4.3.5. SWOT Analysis
19.4.3.6. Strategy Overview
19.4.3.6.1. Marketing Strategy
19.4.3.6.2. Diagnostic Test Strategy
19.4.3.6.3. Channel Strategy
19.4.4. Euro Diagnostica AB
19.4.4.1. Overview
19.4.4.2. Service Portfolio
19.4.4.3. Sales Footprint
19.4.4.4. Key Financials
19.4.4.5. SWOT Analysis
19.4.4.6. Strategy Overview
19.4.4.6.1. Marketing Strategy
19.4.4.6.2. Diagnostic Test Strategy
19.4.4.6.3. Channel Strategy
19.4.5. Thermo Fisher Scientific Inc.
19.4.5.1. Overview
19.4.5.2. Service Portfolio
19.4.5.3. Sales Footprint
19.4.5.4. Key Financials
19.4.5.5. SWOT Analysis
19.4.5.6. Strategy Overview
19.4.5.6.1. Marketing Strategy
19.4.5.6.2. Diagnostic Test Strategy
19.4.5.6.3. Channel Strategy
19.4.6. Qiagen N.V.
19.4.6.1. Overview
19.4.6.2. Service Portfolio
19.4.6.3. Sales Footprint
19.4.6.4. Key Financials
19.4.6.5. SWOT Analysis
19.4.6.6. Strategy Overview
19.4.6.6.1. Marketing Strategy
19.4.6.6.2. Diagnostic Test Strategy
19.4.6.6.3. Channel Strategy
19.4.7. F. Hoffmann-La Roche Ltd.
19.4.7.1. Overview
19.4.7.2. Service Portfolio
19.4.7.3. Sales Footprint
19.4.7.4. Key Financials
19.4.7.5. SWOT Analysis
19.4.7.6. Strategy Overview
19.4.7.6.1. Marketing Strategy
19.4.7.6.2. Diagnostic Test Strategy
19.4.7.6.3. Channel Strategy
19.4.8. Siemens Healthcare GmbH
19.4.8.1. Overview
19.4.8.2. Service Portfolio
19.4.8.3. Sales Footprint
19.4.8.4. Key Financials
19.4.8.5. SWOT Analysis
19.4.8.6. Strategy Overview
19.4.8.6.1. Marketing Strategy
19.4.8.6.2. Diagnostic Test Strategy
19.4.8.6.3. Channel Strategy
19.4.9. Janel Group (Antibodies Inc.)
19.4.9.1. Overview
19.4.9.2. Service Portfolio
19.4.9.3. Sales Footprint
19.4.9.4. Key Financials
19.4.9.5. SWOT Analysis
19.4.9.6. Strategy Overview
19.4.9.6.1. Marketing Strategy
19.4.9.6.2. Diagnostic Test Strategy
19.4.9.6.3. Channel Strategy
20. Assumptions and Acronyms Used
21. Research Methodology